3,111
Views
10
CrossRef citations to date
0
Altmetric
Capacity Building

ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas

ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , , , , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , , , , , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , , ORCID Icon, , , ORCID Icon & show all
Article: 1666566 | Received 18 Apr 2019, Accepted 23 Aug 2019, Published online: 23 Oct 2019

References

  • Heymann DL, Hodgson A, Sall AA, et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet. 2016;387:719–16.
  • Wilder-Smith A, Preet R, Renhorn KE, et al. ZikaPLAN: Zika preparedness Latin American network. Glob Health Action. 2017;10:1398485.
  • Wilder-Smith A, Tissera H, AbuBakar S, et al. Novel tools for the surveillance and control of dengue: findings by the DengueTools research consortium. Glob Health Action. 2018;11:1549930.
  • de Araujo TV, Rodrigues LC, de Alencar Ximenes RA, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis. 2016;16:1356–1363.
  • Miranda-Filho DB, Martelli CM, Ximenes RA, et al. Initial description of the presumed congenital Zika syndrome. Am J Public Health. 2016;106:598–600.
  • Paixao ES, Barreto F, Teixeira MG, et al. History, epidemiology, and clinical manifestations of Zika: a systematic review. Am J Public Health. 2016;106:606–612.
  • Rodrigues LC. Zika: the tragedy and the opportunities. Am J Public Health. 2016;106:582.
  • Albuquerque MF, Souza WV, Mendes AD, et al. Pyriproxyfen and the microcephaly epidemic in Brazil - an ecological approach to explore the hypothesis of their association. Mem Inst Oswaldo Cruz. 2016;111:774–776.
  • Jacobs BC, van den Berg B, Verboon C, et al. International Guillain-Barre syndrome outcome study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barre syndrome. J Peripher Nerv Syst. 2017;22:68–76.
  • Whitehead SS. Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD vaccine? Expert Rev Vaccines. 2016;15:509–517.
  • Song BH, Yun SI, Woolley M, et al. Zika virus: history, epidemiology, transmission, and clinical presentation. J Neuroimmunol. 2017;308:50–64.
  • Awadh A, Chughtai AA, Dyda A, et al. Does Zika virus cause microcephaly - applying the Bradford Hill viewpoints. PLoS Curr. 2017;9.
  • Wilder-Smith A, Wei Y, Araujo TVB, et al. Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children. BMJ Open. 2019;9:e026092.
  • de Araujo TVB, Ximenes RAA, Miranda-Filho DB, et al. Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study. Lancet Infect Dis. 2018;18:328–336.
  • Sheldrick RC, Perrin EC. Evidence-based milestones for surveillance of cognitive, language, and motor development. Acad Pediatr. 2013;13:577–586.
  • Prechtl HF, Einspieler C, Cioni G, et al. An early marker for neurological deficits after perinatal brain lesions. Lancet. 1997;349:1361–1363.
  • Msall ME. Measuring outcomes after extreme prematurity with the Bayley-III Scales of infant and toddler development: a cautionary tale from Australia. Arch Pediatr Adolesc Med. 2010;164:391–393.
  • Lopes Moreira ME, Nielsen-Saines K, Brasil P, et al. Neurodevelopment in infants exposed to Zika virus in Utero. N Engl J Med. 2018;379:2377–2379.
  • Dos Santos SFM, Soares FVM, de Abranches AD, et al. Infants with microcephaly due to ZIKA virus exposure: nutritional status and food practices. Nutr J. 2019;18:4.
  • Einspieler C, Utsch F, Brasil P, et al. Association of infants exposed to prenatal Zika virus infection with their clinical, neurologic, and developmental status evaluated via the general movement assessment tool. JAMA Network Open. 2019;2:e187235.
  • Albuquerque MSV, Lyra TM, Melo APL, et al. Access to healthcare for children with congenital Zika syndrome in Brazil: perspectives of mothers and health professionals. Health Policy Plan. 2019.
  • Duttine A, Smythe T, Calheiro de Sa MR, et al. Development and assessment of the feasibility of a Zika family support programme: a study protocol. Wellcome Open Res. 2019;4:80.
  • Orioli IM, Dolk H, Lopez-Camelo JS, et al. Prevalence and clinical profile of microcephaly in South America pre-Zika, 2005–14: prevalence and case-control study. BMJ. 2017;359:j5018.
  • Mier YT-RL, Delorey MJ, Sejvar JJ, et al. Guillain-Barre syndrome risk among individuals infected with Zika virus: a multi-country assessment. BMC Med. 2018;16:67.
  • Mehta R, Soares CN, Medialdea-Carrera R, et al. The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series. PLoS Negl Trop Dis. 2018;12:e0006212.
  • Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French polynesia: a case-control study. Lancet. 2016;387:1531–1539.
  • Parra B, Lizarazo J, Jimenez-Arango JA, et al. Guillain-Barre syndrome associated with Zika virus infection in Colombia. N Engl J Med. 2016;375:1513–1523.
  • Leonhard SE, Lant S, Jacobs BC, et al. Zika virus infection in the returning traveller: what every neurologist should know. Pract Neurol. 2018;18:271–277.
  • Cumberworth SL, Barrie JA, Cunningham ME, et al. Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected. Acta Neuropathol Commun. 2017;5:50.
  • Fischer C, Drosten C, Drexler JF. The difficulties in obtaining reliable Zika virus diagnostics. Lancet Infect Dis. 2019;19:240–241.
  • Goncalves A, Peeling RW, Chu MC, et al. Innovative and new approaches to laboratory diagnosis of Zika and dengue: a meeting report. J Infect Dis. 2018;217:1060–1068.
  • Xu X, Vaughan K, Weiskopf D, et al. Identifying candidate targets of immune responses in Zika virus based on homology to epitopes in other flavivirus species. PLoS Curr. 2016;8.
  • Grifoni A, Pham J, Sidney J, et al. Prior dengue virus exposure shapes T cell immunity to Zika virus in humans. J Virol. 2017;91.
  • Ricciardi MJ, Magnani DM, Grifoni A, et al. Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naive individual during the 2016 outbreak in Miami, FL. PLoS Negl Trop Dis. 2017;11:e0006000.
  • Grifoni A, Costa-Ramos P, Pham J, et al. Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of Zika virus-specific CD8(+) T cells. J Immunol. 2018;201:3487–3491.
  • Metz SW, Gallichotte EN, Brackbill A, et al. In vitro assembly and stabilization of dengue and Zika virus envelope protein homo-dimers. Sci Rep. 2017;7:4524.
  • Premkumar L, Collins M, Graham S, et al. Development of envelope protein antigens to serologically differentiate Zika virus infection from dengue virus infection. J Clin Microbiol. 2018;56.
  • Montoya M, Collins M, Dejnirattisai W, et al. Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas. J Infect Dis. 2018;218:536–545.
  • Pettersson JH, Eldholm V, Seligman SJ, et al. How did Zika virus emerge in the Pacific Islands and Latin America? MBio. 2016;7.
  • Falconar AK, Martinez F. The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease. PLoS One. 2011;6:e21024.
  • Pettersson JH, Bohlin J, Dupont-Rouzeyrol M, et al. Re-visiting the evolution, dispersal and epidemiology of Zika virus in Asia. Emerg Microbes Infect. 2018;7:79.
  • van Boheemen S, Tas A, Anvar SY, et al. Quasispecies composition and evolution of a typical Zika virus clinical isolate from Suriname. Sci Rep. 2017;7:2368.
  • Mead PS, Duggal NK, Hook SA, et al. Zika virus shedding in semen of symptomatic infected men. N Engl J Med. 2018;378:1377–1385.
  • Yakob L, Kucharski A, Hue S, et al. Low risk of a sexually-transmitted Zika virus outbreak. Lancet Infect Dis. 2016;16:1100–1102.
  • Faria NR, Quick J, Claro IM, et al. Establishment and cryptic transmission of Zika virus in Brazil and the Americas. Nature. 2017;546:406–410.
  • Massad E, Burattini MN, Khan K, et al. On the origin and timing of Zika virus introduction in Brazil. Epidemiol Infect. 2017;1–10.
  • O’Reilly KM, Lowe R, Edmunds WJ, et al. Projecting the end of the Zika virus epidemic in Latin America: a modelling analysis. BMC Med. 2018;16:180.
  • Duong V, Dussart P, Buchy P. Zika virus in Asia. Int J Infect Dis. 2017;54:121–128.
  • Watts AG, Huber C, Bogoch II, et al. Potential Zika virus spread within and beyond India. J Travel Med. 2018;25.
  • Hamer DH, Chen LH. Zika in Angola and India. J Travel Med. 2019;26.
  • Massad E, Coutinho FAB, Wilder-Smith A. Modelling an optimum vaccination strategy against ZIKA virus for outbreak use. Epidemiol Infect. 2019;147:e196.
  • Glaesser D, Kester J, Paulose H, et al. Global travel patterns: an overview. J Travel Med. 2017;24.
  • Leder K, Grobusch MP, Gautret P, et al. Zika beyond the Americas: travelers as sentinels of Zika virus transmission. A GeoSentinel analysis, 2012 to 2016. PLoS One. 2017;12:e0185689.
  • Wilder-Smith A, Chang CR, Leong WY. Zika in travellers 1947–2017: a systematic review. J Travel Med. 2018;25.
  • Wang G, Zheng W, Zhu S, et al. A cluster of Zika virus infection among travellers returning to China from Samoa: a case tracing study. J Travel Med. 2018;25.
  • Zhang J, Jin X, Zhu Z, et al. Early detection of Zika virus infection among travellers from areas of ongoing transmission in China. J Travel Med. 2016;23:taw047.
  • Summers DJ, Acosta RW, Acosta AM. Zika virus in an American recreational traveler. J Travel Med. 2015;22:338–340.
  • Sokal A, D’Ortenzio E, Houhou-Fidouh N, et al. Zika virus infection: report of the first imported cases in a Paris travel centre. J Travel Med. 2016;24:taw066.
  • Shinohara K, Kutsuna S, Takasaki T, et al. Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urines. J Travel Med. 2016;23:tav011.
  • Katanami Y, Kutsuna S, Taniguchi S, et al. Detection of Zika virus in a traveller from Vietnam to Japan. J Travel Med. 2017;24.
  • Torresi J, Steffen R. Redefining priorities towards graded travel-related infectious disease research. J Travel Med. 2017;24.
  • Leder K, Steffen R, Cramer JP, et al. Risk assessment in travel medicine: how to obtain, interpret, and use risk data for informing pre-travel advice. J Travel Med. 2015;22:13–20.
  • Wilder-Smith A, Boggild AK. Sentinel surveillance in travel medicine: 20 years of GeoSentinel publications (1999–2018). J Travel Med. 2018;25.
  • Chen LH, Leder K, Barbre KA, et al. Business travel-associated illness: a GeoSentinel analysis. J Travel Med. 2018;25.
  • Boggild AK, Geduld J, Libman M, et al. Spectrum of illness in migrants to Canada: sentinel surveillance through CanTravNet. J Travel Med. 2019;26.
  • Angelo KM, Haulman NJ, Terry AC, et al. Illness among US resident student travellers after return to the USA: a GeoSentinel analysis, 2007–17. J Travel Med. 2018;25.
  • Boggild AK, Esposito DH, Kozarsky PE, et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel surveillance network. Ann Intern Med. 2015;162:757–764.
  • Michal Stevens A, Esposito DH, Stoney RJ, et al. Clostridium difficile infection in returning travellers. J Travel Med. 2017;24.
  • Salzer HJF, Stoney RJ, Angelo KM, et al. Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997–2017. J Travel Med. 2018;25.
  • Barbosa F, Barnett ED, Gautret P, et al. Bordetella pertussis infections in travelers: data from the GeoSentinel global network. J Travel Med. 2017;24.
  • Neumayr A, Munoz J, Schunk M, et al. Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: TropNet data from the DengueTools research initiative. Euro Surveill. 2017;22.
  • Huits R, Van den Bossche D, Eggermont K, et al. Incidence of Zika virus infection in a prospective cohort of Belgian travellers to the Americas in 2016. Int J Infect Dis. 2019;78:39–43.
  • Huits R, Maniewski U, Van den Bossche D, et al. A cross-sectional analysis of Zika virus infection in symptomatic and asymptomatic non-pregnant travellers: experience of a European reference center during the outbreak in the Americas. Travel Med Infect Dis. 2019;27:107–114.
  • Wilder-Smith A. Can dengue virus be sexually transmitted? J Travel Med. 2019;26.
  • Molton JS, Low I, Choy MMJ, et al. Dengue virus not detected in human semen. J Travel Med. 2018;25.
  • Huits R, De Smet B, Arien KK, et al. Zika virus in semen: a prospective cohort study of symptomatic travellers returning to Belgium. Bull World Health Organ. 2017;95:802–809.
  • Chen LH, Hamer DH. Zika virus and sexual transmission: updated preconception guidance. J Travel Med. 2018;25.
  • Quam MB, Wilder-Smith A. Estimated global exportations of Zika virus infections via travellers from Brazil from 2014 to 2015. J Travel Med. 2016;23:taw059.
  • Tuite AR, Thomas-Bachli A, Acosta H, et al. Infectious disease implications of large-scale migration of Venezuelan nationals. J Travel Med. 2018;25.
  • Massad E, Tan SH, Khan K, et al. Estimated Zika virus importations to Europe by travellers from Brazil. Glob Health Action. 2016;9:31669.
  • Furuya-Kanamori L, Liang S, Milinovich G, et al. Co-distribution and co-infection of chikungunya and dengue viruses. BMC Infect Dis. 2016;16:84.
  • Yakob L, Walker T. Zika virus outbreak in the Americas: the need for novel mosquito control methods. Lancet Glob Health. 2016;4:e148–e9.
  • Ritchie SA. Wolbachia and the near cessation of dengue outbreaks in Northern Australia despite continued dengue importations via travellers. J Travel Med. 2018;25.
  • Black WCT, Alphey L, James AA. Why RIDL is not SIT. Trends Parasitol. 2011;27:362–370.
  • Yakob L, Funk S, Camacho A, et al. Aedes aegypti control through modernized, integrated vector management. PLoS Curr. 2017;9.
  • Sinkins SP. Wolbachia and arbovirus inhibition in mosquitoes. Future Microbiol. 2013;8:1249–1256.
  • Harris AF, McKemey AR, Nimmo D, et al. Successful suppression of a field mosquito population by sustained release of engineered male mosquitoes. Nat Biotechnol. 2012;30:828–830.
  • Schreck CE, Haile DG, Kline DL. The effectiveness of permethrin and deet, alone or in combination, for protection against Aedes taeniorhynchus. Am J Trop Med Hyg. 1984;33:725–730.
  • Lalani T, Yun H, Tribble D, et al. A comparison of compliance rates with anti-vectorial protective measures during travel to regions with dengue or chikungunya activity, and regions endemic for Plasmodium falciparum malaria. J Travel Med. 2016;23:taw043.
  • Goodyer L, Schofield S. Mosquito repellents for the traveller: does picaridin provide longer protection than DEET? J Travel Med. 2018;25:S10–S5.
  • Beran D, Byass P, Gbakima A, et al. Research capacity building-obligations for global health partners. Lancet Glob Health. 2017;5:e567–e8.
  • Shanks GD. Could Ross River virus be the next Zika? J Travel Med. 2019;26.
  • Gubler DJ. Pandemic yellow fever: a potential threat to global health via travelers. J Travel Med. 2018;25.
  • Rezza G. Chikungunya is back in Italy: 2007–2017. J Travel Med. 2018;25.
  • Acosta-Ampudia Y, Monsalve DM, Rodriguez Y, et al. Mayaro: an emerging viral threat? Emerg Microbes Infect. 2018;7:163.
  • Heymann DL, Liu J, Lillywhite L. Partnerships, not parachutists, for Zika research. N Engl J Med. 2016;374:1504–1505.